ELENA PATEL: Open Payments
NPI 1164041489 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$438 in 21 payments from 8 companies in 2025. Trend: 2023 $327 · 2024 $888 · 2025 $438
Food & beverage: $438
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $106 |
| ABBVIE INC. | 6 | $103 |
| Neurocrine BioSciences, Inc. | 4 | $85 |
| Otsuka America Pharmaceutical, Inc. | 3 | $62 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $30 |
| Gilead Sciences, Inc. | 1 | $18 |
| PFIZER INC. | 1 | $17 |
| Abbott Laboratories | 1 | $17 |
Products named: COBENFY, VRAYLAR, INGREZZA, Kerendia, REXULTI, ABILIFY ASIMTUFII, ABILIFY MAINTENA, PREVNAR 20.
Industry payments across NC — which companies pay providers there.
